Anogeissus leiocarpus extract on the parasite nematode Onchocerca ochengi and on drug resistant mutant strains of the free-living nematode Caenorhabditis elegans

Veterinary Parasitology

Volumn 190, Issue 1-2, 2012, Pages 136-142

  Ndjonka, Dieudonné ^a,b   Ajonina Ekoti, Irene ^b   Djafsia, Boursou ^a   Lüersen, Kai ^b   Abladam, Elias ^a   Liebau, Eva ^b  

^a UNIVERSITY OF NGAOUNDERE   (Cameroon)

^b Institute for Zoophysiology   (Germany)

Author keywords

Albendazole; Anogeissus leiocarpus; Caenorhabditis elegans; Ivermectin; Levamisole; Onchocerca ochengi

Indexed keywords

ALBENDAZOLE; ALCOHOL; ANOGEISSUS LEIOCARPUS EXTRACT; IVERMECTIN; LEVAMISOLE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANOGEISSUS LEIOCARPUS; ANTHELMINTIC ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; FEMALE; GENE MUTATION; HUMAN; MALE; MEDICINAL PLANT; MICROFILARIA (NEMATODE LARVA); MORTALITY; NEMATODIASIS; NONHUMAN; ONCHOCERCA; ONCHOCERCA OCHENGI; ONCHOCERCIASIS; PARASITE CULTIVATION; PARASITE SURVIVAL;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; CAENORHABDITIS ELEGANS; COMBRETACEAE; FEMALE; IVERMECTIN; LEVAMISOLE; MALE; MUTATION; ONCHOCERCA; ONCHOCERCIASIS; PLANT EXTRACTS;

ANOGEISSUS LEIOCARPA; BOS; CAENORHABDITIS ELEGANS; ONCHOCERCA OCHENGI;

EID: 84867140471     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2012.05.027     Document Type: Article

References (34)

1. Aceves J., Erlij D., Martínez-Marañón R. The mechanism of the paralysing action of tetramisole on Ascaris somatic muscle. Br. J. Pharmacol. 1970, 38:602-607.
2. Aubry M.L., Cowell P., Davey M.J., Shevde S. Aspects of the pharmacology of a new anthelmintic: pyrantel. Br. J. Pharmacol. 1970, 38:332-344.
3. Ali M.M., Mukhtar M.M., Baraka O.Z., Homeida M.M., Kheir M.M., Mackenzie C.D. Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. Acta Trop. 2002, 84:49-53.
4. Awadzi K., Boakye D.A., Edwards G., Opoku N.O., Attah S.K., Osei-Atweneboana M.Y., Lazdins-Helds J.K., Ardrey A.E., Addy E.T., Quartey B.T., Ahmed K., Boatin B.A., Soumbey-Alley E.W. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 2004, 98:231-249.
5. Beach M.J., Streit T.G., Addiss D.G., Prospere R., Roberts J.M., Lammie P.J. Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and wuchereria bancrofti infections in haitian schoolchildren. Am. J. Trop. Med. Hyg. 1999, 60:479-486.
6. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
7. Borsboom G.J., Boatin B.A., Nagelkerke N.J., Agoua H., Akpoboua K.L., Alley E.W., Bissan Y., Renz A., Yameogo L., Remme J.H., Habbema J.D. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J. 2003, 2:8.
8. Bruggisser R., von Daeniken K., Jundt G., Schaffner W., Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta. Med. 2002, 68:445-448.
9. Burglin T.R., Lobos E., Blaxter M.L. Caenorhabditis elegans as a model for parasitic nematodes. Int. J. Parasitol. 1998, 28:395-411.
10. Cho-Ngwa F., Abongwa M., Ngemenya M.N., Nyongbela K.D. Selective activity of extracts of Margaritaria discoidea and Homalium africanum on Onchocerca ochengi. BMC Complement. Alternat. Med. 2010, 10-62 (October 28). 10.1186/1472-6882.
11. Culetto E., Baylis H.A., Richmond J.E., Jones A.K., Fleming J.T., Squire M.D., Lewis J.A., Sattelle D.B. The Caenorhabditis elegans unc-63 gene encodes a levamisole sensitive nicotinic acetylcholine. J. Biol. Chem. 2004, 279:42476-42483.
12. Dent J.A., Smith M.M., Vassilatis D.K., Avery L. The genetics of ivermectin resistance in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:2674-2679.
13. Driscoll M., Dean E., Reilly E., Bergholz E., Chalfie M. Genetic and Molecular Analysis of a Caenorhabditis elegans β-tubulin that conveys benzimidazole sensitivity. J. Cell Biol. 1989, 109:2993-3003.
14. Fleming J.T., Squire M.D., Barnes T.M., Tornoe C., Matsuda K., Ahnn J., Fire A., Sulston J.E., Barnard E.A., Sattelle D.B., Lewis J.A. Caenorhabditis elegans levamisol resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits. J. Neurosci. 1997, 15:5843-5857.
15. Gendrel M., Rapti1 G., Richmond J.E., Bessereau J.L. A secreted complement-control-related protein ensures acetylcholine receptor clustering. Nature 2009, 461:992-996.
16. Gilbert J., Nfon C.K., Makepeace B.L., Njongmeta L.M., Hastings I.M., Pfarr K.M., Renz A., Tanya V.N., Trees A.J. Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). J. Infect. Dis. 2005, 192:1483-1493.
17. Gosai S.J., Kwak J.H., Luke C.J., Long O.S., King D.E., Kovatch K.J., Johnston P.A., Shun T.Y., Lazo J.S., Perlmutter D.H., Silverman G.A., Pak S.C. Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z. PLoS One 2010, 11:1-16.
18. Jones M.R., Huang J.C., Chua S.Y., Baillie D.L., Ann M., Rose A.M. The atm-1 gene is required for genome stability in Caenorhabditis elegans. Mol. Genet. Genomics 2012, 287:325-335.
19. Kampkotter A., Gombitang-Nkwonkam C., Zurawski R.F., Timpel C., Chovolou Y., Watjen W., Kahl R. Investigations of protective effects of the Xavonoids quercetin and rutin on stress resistance in the model organism Caenorhabditis elegans. Toxicology 2007, 234:113-123.
20. Klapper M., Ehmke M., Palgunow D., Böhme M., Matthäus C., Bergner G., Dietzek B., Popp J., Döring F. Fluorescence-based fixative and vital staining of lipid droplets in Caenorhabditis elegans reveal fat stores using microscopy and flow cytometry approaches. J. Lipid Res. 2011, 52:1281-1293.
21. Lacey E. Mode of action of benzimidazoles. Parasitol. Today 1990, 6:112-115.
22. Laughton D.L., Lunt G.G., Wolstenholme A.J. Reporter gene constructs suggest that the Caenorhabditis elegans avermectin receptor beta-subunit is expressed solely in the pharynx. J. Exp. Biol. 1997, 200:1509-1514.
23. Lewis J.A., Wu C.H., Berg H., Levine J.H. The genetics of levamisole resistance in the nematode Caenorhabditis elegans. Genetics 1980, 95:905-928.
24. Loveland B.E., Johns T.G., Mackay I.R., Vaillant F., Wang Z.X., Hertzog P.J. Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem. Int. 1992, 27:501-510.
25. Lubega G.W., Klein R.D., Geary T.G., Prichard R.K. Haemonchus contortus: the role of two β-tubulin gene subfamilies in the resistance to benzimidazole anthelmintics. Biochem. Pharmacol. 1994, 47:1705-1715.
26. Monglo D., Njongmeta L.M., Musongong G., Ngassoum M., Nukenine E.N. Evaluation of anthelmintic potential of ethanolic plant extracts from Northern Cameroon against eggs and infective larvae of Haemonchus contortus. J. Biol. Sci. 2006, 6:426-433.
27. Ndjonka D., Agyare C., Lüersen K., Djafsia B., Achukwi D., Nukenine E.N., Hensel A., Liebau E. In vitro activity of Cameroonian and Ghanaian medicinal plants on parasitic (Onchocerca ochengi) and free-living (Caenorhabditis elegans) nematodes. J. Helminthol. 2011, 85:304-312.
28. Osei-Atweneboana M.Y., Eng J.K.L., Boakye D.A., Gyapong J.O., Prichard R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. The Lancet 2007, 369:2021-2029.
29. Roos M.H., Boersema J.H., Borgsteede F.H., Cornelissen J., Taylor M., Ruitenberg E.J. Molecular analysis of selection for benzimidazole resistance in the sheep parasite Haemonchus contortus. Mol. Biochem. Parasitol. 1990, 43:77-88.
30. Thein M.C., Winter A.D., Stepek G., McCormack G., Stapleton G., Johnstone I.L., Page A.P. Combined extracellular matrix cross-linking activity of the peroxidase MLT-7 and the dual oxidase BLI-3 is critical for post-embryonic viability in Caenorhabditis elegans. J. Biol. Chem. 2009, 284:17549-17563.
31. Vassilatis D.K., Arena J.P., Plasterk R.H., Wilkinson H.A., Schaeffer J.M., Cully D.F., Van der Ploeg L.H. Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization. J. Biol. Chem. 1997, 272:33167-33174.
32. Waterman C., Smith R.A., Pontiggia L., DerMarderosian A. Anthelmintic screening of Sub-Saharan African plants used in traditional medicine. J. Ethnopharmacol. 2010, 127:755-759.
33. World Health Organization, 1995. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. WHO Technical Report Series 852. World Health Organization, Geneva.
34. Yates D.M., Portillo V., Wolstenholme A.J. The avermectin receptors of Haemonchus contortus and Caenorhabditis elegans. Int. J. Parasitol. 2003, 33:1183-1193.